There has been videos discussing the impact and potential demand for VPT give the COVID pandemic and cardiac complications being seen.
Plenty if excitement and predictions of units needed, sales, buyout of the company....
Great...
'This is important,and promising, but what are the facts that there is truly any demand or requirement for this technology for investigation of the cardiac manifestations of COVID-19?
Is there evidence that existing technology is inadequate, or that there are other advances that are not available?
Please-provide the evidence for this, links to papers, interviews with unpaid cardiologists, research articles....
I have done a superficial dive and from what I can tell, existing tech tools are working and are being used by physicians now , and that physicians like the ability to use handheld ultrasound VSACAN extend , as a rapid tool to ne used to limit time with patients
‘With that system [Vscan Extend], I’m in the room 10 minutes max. With the other system, if I had to boot it up, boot it down, clean it all (because we do a clean in the room and a clean out of the room) you’re talking extensive time, like over an hour.”
https://www.gehealthcare.com/article/using-handheld-ultrasound-to-monitor-heart-conditions-in-covid-19-patients
I can find no evidence that any thought leader in Cardiology is stating that there is a need for the VPTtechnology, or such tech that doesn’t exist, nor has any cardiologist, that is independent, out making statements about the huge promise of VPT
I saw a cryptic statement here by a Dr who is anonymous ????
As noted in posts earlier, there’s not even any evidence that there’s any push for studies using this VPT technology with Covid patients
All this promotion about multiple units being sold to monitor patients, speculation, being stated by those who have a vested interest with the machine, and cannot be validated in fact. Similarly there is no evidence of sales to this date.
That, and there is evidence that some of the Giants in ultrasound or are now working actively an artificial intelligence and have approved devices
https://www.ge.com/news/press-releases/ge-healthcare-receives-fda-clearance-vivid-ultra-edition-ai-powered-cardiovascular
Also there is active research going on in this area, and in these papers, no mention of VPT as a threat
‘The proposed PLANet was extensively evaluated on the dataset of cardiac acquisitions for multi-structure ultrasound segmentation (CAMUS) and sub-EchoNet-Dynamic, which are two large-scale and public 2D echocardiography datasets. The experimental results show that PLANet performs better than traditional and deep learning-based segmentation methods on geometrical and clinical metrics. Moreover, PLANet can complete the segmentation of heart structures in 2D echocardiography in real time, indicating a potential to assist cardiologists accurately and efficiently.” Source: https://www.sciencedirect.com/science/article/pii/S1361841520302371?via%3Dihub
How does this compare to Ventripoints system?
What do others know of the key scientific differences of VPT vis a vis these new AI initiatives?
How does this differ (especially regarding accuracy (ie ICC using VPTs system-which are excellent according to the small Uof A study with 0.98 for LVEF, for example )
Why is there no indication in the scientific literature, or amongst those who have approved agents, to have any discussion of VPT , or is there any significant sales being announced?
I keep hearing and seeing posters that are saying that the sales were going to be announced that there’s a big news release coming out. But none of this jas happened, and there’s just a bunch of videos out there
So asking questions, and of course-I am not an expert(whom you should talk with) in this area, nor should anyone buy/sell based on what they read here(especially anything I say since I am the board idiot among other things )
Can anyone actually provide data, or are we onto a fresh round of insults, accusations, and hand waving?